Minomic Launches US Prospective Study of MiCheck® Prostate Cancer Test

11:00 EDT 17 Jul 2017 | Businesswire
This article has expired, however you can still download the PDF.
Novel prostate cancer screening technology targeting commercialization in 2017 Verification of test accuracy and reliability for CLIA lab access Minomic International Ltd, an Australian immuno-oncology company, has ...

Other Sources for this Article

Minomic International Ltd
Brad Walsh, Ph.D., +61 413-231-296
Chief Executive Officer


More From BioPortfolio on "Minomic Launches US Prospective Study of MiCheck® Prostate Cancer Test"

Quick Search

Relevant Topics

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...